Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

New data on inflammation in multiple sclerosis using PET-MRI

Published on: 20/10/2021 Reading time: 1 min
image SLA
Retour à la recherche

Several studies by Prof. Bruno Stankoff's team "Remyelination in multiple sclerosis: from biology to clinical translation", highlight new mechanisms of brain inflammation in multiple sclerosis, thanks to new imaging tools based on the combination of magnetic resonance imaging (MRI) and positron emission tomography (PET).

Using PET-MRI, Prof. Stankoff's team has just published in the journal Radiology the results of a study of 97 MS patients and 44 healthy controls showing abnormalities (increased volume and inflammation) in the choroid plexuses of the patients. The choroid plexuses are structures located in the cerebral ventricles responsible for the production of cerebrospinal fluid, and act as a barrier between the nervous system and the immune system.

These choroidal plexus abnormalities were correlated with brain inflammation, indicating disease activity. These results open a new avenue for the application of imaging of this structure as a marker of the immune response in the brain and point to the choroid plexus as an important player in the pathophysiology of the disease.

cerveau
The choroïd plexuses (circled in red) of MS patients with a remitting form are larger (on the right) than healthy controls’ (on the left)

Work by the same team published in the journal Neurology, shows activation of innate immune cells associated with white matter micro-lesions in MS patients with worsening disability, and that this immune activation follows a gradient centered around the cerebral ventricles, which contain cerebrospinal fluid.

These results obtained thanks to the combination of PET targeting innate immune cells and MRI confirm the existence of a correlation between the activation of these cells around the ventricles, privileged areas of MS lesions in contact with cerebrospinal fluid (CSF), and the worsening of the disability in patients. This suggests that molecules contained in the CSF could worsen the inflammation present in the white matter of patients and thus promote a deleterious evolution of the disease, making these molecules candidates for future research into treatments.

image
Activated innate immune cells in a patient with MS using PET-scan around ventricles.

Sources

https://pubmed.ncbi.nlm.nih.gov/33737372/
Poirion E, Tonietto M, Lejeune FX, Ricigliano VAG, Boudot de la Motte M, Benoit C, Bera G, Kuhnast B, Bottlaender M, Bodini B, Stankoff B. Neurology. 2021 Apr 6;96(14):e1865-e1875.
https://pubmed.ncbi.nlm.nih.gov/34254858/
Ricigliano VAG, Morena E, Colombi A, Tonietto M, Hamzaoui M, Poirion E, Bottlaender M, Gervais P, Louapre C, Bodini B, Stankoff B. Radiology. 2021 Oct;301(1):166-177.
https://pubmed.ncbi.nlm.nih.gov/34545219/
Bodini B, Tonietto M, Airas L, Stankoff B. Nat Rev Neurol. 2021 Sep 20.

Our news on the subject

Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
La qualité des mitochondries durant le neurodéveloppement est cruciale pour la santé cérébrale
Mitochondrial quality during neurodevelopment is crucial for brain health
The anomalies underlying neurodegenerative diseases may arise during development—decades before the first symptoms appear. This hypothesis is gaining traction thanks to a new study published in Nature Communications. According to researchers from the...
10.20.2025 Research, science & health
lauréat de la 3ème édition de l’appel à projets NeurAL
Brahim Nait Oumesmar, winner of the 3rd NeurAL call for projects
This year, NeurAL, Paris Brain Institute’s start-up studio, has selected a project by the researcher Brahim Nait Oumesmar that seeks to develop a remyelinating treatment for multiple sclerosis. The winner will benefit from personalized support and...
10.15.2025 Research applications
sequencage adn
Intellectual development disorders: two new genes under the microscope
A Franco-German international research team has identified two new genes that play a role in the onset of intellectual development disorders (IDD), also known as intellectual disabilities. Researchers have successfully developed two new types of test...
12.08.2025 Research, science & health
Troubles du Développement Intellectuel
The "RNU-Splice" project receives support from the health sponsorship of AXA Mutuals
Intellectual development disorders (IDD) affect 2 to 3 per cent of the population and are characterized by impaired cognitive functions, impacting learning. TDI thus has an impact on coping skills with implications for daily life and is a major...
10.08.2025 Support
See all our news